NO MORE PPIS
ANCHOR LEAD: MANY PEOPLE WITH ASTHMA DON’T BENEFIT FROM A POPULAR ANTACID, ELIZABETH TRACEY REPORTS
Proton pump inhibitors, a popular class of antacid medications sold over the counter, don’t help improve asthma control, a Johns Hopkins study has established. Robert Wise, the study’s lead author, explains.
WISE: Gastroesophageal reflux or backing up of acid into the esophagus is very common in people with asthma. About half of patients with asthma have that and most of them have no symptoms of heartburn. Because of that many doctors have thought that treating patients with asthma that’s poorly controlled for gastroesophageal reflux might help their asthma. What we found in this study was that these drugs, proton pump inhibitors had no benefit for these patients in terms of their asthma. :33
Wise says people with asthma who do have symptoms of gastroesophageal reflux or heartburn may still benefit from these medications or other classes of antacids. At Johns Hopkins, I’m Elizabeth Tracey.